15 Fibromyalgia Clinical Trials in Denver, CO (2026)

Q: How do I join a clinical trial in Denver?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you.

Recruiting Fibromyalgia Studies in Denver

NCT06238622Recruiting

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medic...

Denver, COPHASE31,700 participantsBoehringer Ingelheim

View Study Details

NCT06504589Recruiting

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health d...

Denver, CO400 participantsNicole Hamblett

View Study Details

NCT06806592Recruiting

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Adults 18 years of age and older or above legal age with lung fibrosis related to systemic autoimmune rheumatic disease can participate in this study. People can only take part if they show no improve...

Denver, COPHASE3400 participantsBoehringer Ingelheim

View Study Details

NCT07652658Recruiting

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

This Phase IIb study aims to evaluate the efficacy, safety, and tolerability of 3 doses of AZD8965 treatment compared to placebo in participants with IPF, including those on antifibrotic therapy (nint...

Denver, COPHASE2359 participantsAstraZeneca

View Study Details

NCT06559150Recruiting

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebuli...

Denver, COPHASE2284 participantsVerona Pharma plc

View Study Details

NCT04176198Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

This study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or...

Denver, COPHASE1240 participantsSumitomo Pharma America, Inc.

View Study Details

NCT06683092Recruiting

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

RETRIAL is a multi-site observational study of people with Cystic Fibrosis (PWCF) ages 6 and up starting the new triple-therapy modulator (vanzacaftor/tezacaftor/deutivacaftor (VTD)), after having exp...

Denver, CO200 participantsBoston Children's Hospital

View Study Details

NCT06967805Recruiting

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)...

Denver, COPHASE2164 participantsMediar Therapeutics

View Study Details

NCT06950892Recruiting

Remote Sputum Collection in Cystic Fibrosis

Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections has become more chall...

Denver, CO150 participantsUniversity of Pennsylvania

View Study Details

NCT06296394Recruiting

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

The goal of this observational prospective study is to determine the health impact of parenthood on United States (US) people with CF in the era of CF transmembrane regulator protein (CFTR) modulators...

Denver, CO146 participantsUniversity of Pittsburgh

View Study Details

NCT06968845Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Rationale: LTI-03 is an experimental medication breathed into the lungs using an inhaler. It is being studied for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is a progressive, fatal lung...

Denver, COPHASE2120 participantsRein Therapeutics

View Study Details

NCT07071324Recruiting

CF Wellness Program

This study is a pilot randomized control trial (RCT; N=80) comparing the Cystic Fibrosis Wellness Program (CFWP) to usual care (UC) to evaluate (1) Intervention Adherence (completion of the CFWP Coach...

Denver, CONA80 participantsJohns Hopkins University

View Study Details

NCT06429176Recruiting

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis

The goal of this clinical trial is to learn if drug SPL84 is safe for adult patients with cystic fibrosis (CF). It will also learn if the drug works to treat works to treat CF with a specific mutation...

Denver, COPHASE264 participantsSpliSense Ltd.

View Study Details

NCT06998043Recruiting

Study With Phage for CF Subjects With Pseudomonas Lung Infection

The goal of this Phase 2b clinical trial is to see if nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa (PsA) lung infection in CF subjects. The primary goal is to see if 8 weeks of twi...

Denver, COPHASE263 participantsBiomX Ltd

View Study Details

NCT05248230Recruiting

4D-710 in Adult Patients With Cystic Fibrosis

This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis....

Denver, COPHASE230 participants4D Molecular Therapeutics

View Study Details

About Fibromyalgia Clinical Trials in Denver

Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.

There are currently 15 fibromyalgia clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 4,400 participants. Research is being sponsored by Boehringer Ingelheim, Nicole Hamblett, AstraZeneca and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fibromyalgia Clinical Trials in Denver — FAQ

Are there fibromyalgia clinical trials in Denver?

Yes, there are 15 fibromyalgia clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Denver?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.

Are clinical trials in Denver free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.

What fibromyalgia treatments are being tested?

The 15 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.

Data updated August 30, 2026 from ClinicalTrials.gov